AIRO Q4 Results: Revenue Up But Misses Wall Street Targets – Eyes 15-25% Growth in 2026
AIRO reported Q4 2025 revenue of $48.3M (up YoY) but missed Wall Street forecasts. 2026 guidance calls for 15-25% growth backed by $150M drone backlog.
NOTRELOAD AI
ImmunityBio Scores $100 Million Cash Boost – $75M Non-Dilutive – to Supercharge Global Expansion
ImmunityBio strengthens its balance sheet with $100 million financing, including $75M non-dilutive funding from Oberland Capital and $25M debt conversion.
Constellation Energy Crashes as 2026 Guidance Misses and Data Center Deals Stay Silent
Constellation Energy tumbled after its 2026 earnings guidance missed Wall Street forecasts and it failed to announce any new AI data-center power deals.
Activist Investor Pushes Snap to Cut Costs and Boost Profits
Activist fund Irenic Capital wants Snap to spin off its smart glasses business, cut jobs, buy back shares, and use AI to improve ad revenue.
FDA Moving to Bring Back Popular Injectable Peptides
The FDA is moving to allow compounding pharmacies to produce over a dozen banned injectable peptides. RFK Jr. says he's a big fan and has used them with great results.
Aehr Test Shares Surge on Major New Silicon Photonics Order for AI Data Centers
Aehr Test Systems wins major new customer for high-power FOX-XP wafer-level burn-in systems for silicon photonics in hyperscale AI data centers.